drugset / Trial / NCT02324985
Phase II Study of AP0302 5% Versus a Vehicle Comparator
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to evaluate the analgesic safety and efficacy of study drug (AP0302) applied topically every 6 hours as compared to a vehicle, in subjects experiencing delayed onset muscle soreness.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-07
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexibuprofen | Small molecule | 5 % | Topical |
Indications
No indication recorded.